z-logo
open-access-imgOpen Access
N‐terminal region of Mannheimia haemolytica leukotoxin serves as a mitochondrial targeting signal in mammalian cells
Author(s) -
Kisiela Dagmara I.,
Aulik Nicole A.,
Atapattu Dhammika N.,
Czuprynski Charles J.
Publication year - 2010
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/j.1462-5822.2010.01445.x
Subject(s) - biology , mitochondrion , signal peptide , microbiology and biotechnology , bacterial outer membrane , peptide sequence , escherichia coli , hemolysin , gene , virulence , biochemistry
Summary Mannheimia haemolytica leukotoxin (LktA) is a member of the RTX toxin family that specifically kills ruminant leukocytes. Previous studies have shown that LktA induces apoptosis in susceptible cells via a caspase‐9‐dependent pathway that involves binding of LktA to mitochondria. In this study, using the bioinformatics tool MitoProt II we identified an N‐terminal amino acid sequence of LktA that represents a mitochondrial targeting signal (MTS). We show that expression of this sequence, as a GFP fusion protein within mammalian cells, directs GFP to mitochondria. By immunoprecipitation we demonstrate that LktA interacts with the Tom22 and Tom40 components of the translocase of the outer mitochondrial membrane (TOM), which suggests that import of this toxin into mitochondria involves a classical import pathway for endogenous proteins. We also analysed the amino acid sequences of other RTX toxins and found a MTS in the N‐terminal region of Actinobacillus pleuropneumoniae ApxII and enterohaemorrhagic Escherichia coli EhxA, but not in A. pleuropneumoniae ApxI, ApxIII, Aggregatibacter a ctinomycetemcomitans LtxA or the haemolysin (HlyA) from uropathogenic strains of E. coli . These findings provide a new evidence for the importance of the N‐terminal region in addressing certain RTX toxins to mitochondria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here